Professor Bruce Robinson AM


Professor Bruce Robinson is an endocrinologist with over 30 years’ leadership experience as an academic physician and scientist across research, healthcare and medicine, and tertiary education.  Bruce has both a Doctorate in Medicine and Master of Science from the University of Sydney.  

Bruce serves as non-executive director of Cochlear Limited.  He is also a non-executive director of ASX-listed pharmaceutical manufacturer Mayne Pharma Group Limited as well as Life sciences company QBiotics Group Limited.  He previously served as a director at medical device start-up Firefly.

Bruce is Chair of the Australian Government’s Taskforce of expert clinicians charged with reviewing the Medicare Benefits Schedule and is Chair of Australia’s peak advisory and funding body for medical research, National Health and Medical Research Council.

He is the former head of the Cancer Genetics Unit at the Kolling Institute of Medical Research and Head of Medicine at Royal North Shore Hospital and continues to practice at Sydney’s Royal North Shore Hospital.  Bruce is the former Dean at The University of Sydney’s Medical School.

Bruce’s career spans across the globe.  His molecular research work was performed at the Brigham and Women’s Hospital and the Boston Children’s Hospital, both affiliates of Harvard Medical School.  Bruce also holds a strong interest in furthering relations between Australia and Asia, and is the founding chairman of Hoc Mai, the Australia-Vietnam Medical Foundation. The foundation sponsors and supports medical, nursing, allied health and scientific exchanges between Australia and Vietnam. He was awarded the People’s Health Medal by the Vietnamese Government in 2008. 

We’d love to hear from you.